Literature DB >> 3034789

Proliferation of human testicular tumours.

H M Rabes.   

Abstract

Whole tumour perfusion with radioactive DNA precursors reveals that proliferation of human testicular tumours differs widely depending on type and stage of development. In seminomas a homogeneous distribution of proliferating cells at early stages is followed by a shift of the growth fraction to the periphery at advanced stage. Embryonal carcinomas show a chessboard-like pattern of proliferating fractions with high 3H-thymidine labelling indices and short tpot. In mature teratomas proliferation is low. It increases in immature teratocarcinomas. Lack of proliferation is observed in beta-hCG-positive syncytiotrophoblastic cells of choriocarcinomas, the growth fraction being limited to the cytotrophoblastic compartment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034789     DOI: 10.1111/j.1365-2605.1987.tb00174.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  4 in total

1.  Evidence of interepithelial seminoma spread into the rete testis by immunostaining of paraffin sections with antibodies against cytokeratin and vimentin.

Authors:  W Düe; V Loy
Journal:  Urol Res       Date:  1988

2.  Ribonucleases endowed with specific toxicity for spermatogenic layers.

Authors:  Josef Matoušek; Jin-Soo Kim; Josef Souček; Jan Rìha; Marc Ribó; Peter A Leland; Ronald T Raines
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1997-12       Impact factor: 2.231

3.  Immunohistological determination of proliferative activity in seminomas.

Authors:  W Düe; K P Dieckmann; V Loy
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

4.  A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).

Authors:  Robert A Huddart; Rhian Gabe; Fay H Cafferty; Philip Pollock; Jeff D White; Jonathan Shamash; Michael H Cullen; Sally P Stenning
Journal:  Eur Urol       Date:  2014-07-04       Impact factor: 20.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.